Dr. Reddys Labs (RDY) Receives Tentative FDA Approval for Zenavod as Rosacea Treatment
Tweet Send to a Friend
Dr. Reddy's Laboratories (NYSE: RDY) announced the U.S. Food and Drug Administration (US FDA) tentative approval for Zenavod (doxycycline) Capsules ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
